US healthcare system is ‘bottleneck’ to adoption of Biogen’s Alzheimer drug
Biogen Inc noted delayed uptake of its Alzheimer’s drug, Aduhelm, in the US, but said it continues to believe in the treatment’s long-term potential.
Archives for October 25, 2021
Waters and University of Delaware in bioprocessing innovation tie-up
Waters has announced a five-year investment to develop new analytical technology for bioprocessing and biomanufacturing with the University of Delaware.
Fulfilling Global Temperature-Controlled Transport and Storage Needs for Clinical Trials
Paid for and content provided by Yourway
With 21 facilities located globally and 260,000 ft2 of total capacity, Yourway is dedicated to transporting temperature-controlled clinical trial materials, including ancillary supplies, around the world within mere hours.
Pfizer/BioNTech COVID-19 booster dose demonstrates high efficacy
Pfizer and BioNTech have announced topline results from a Phase 3 trial for their COVID-19 vaccine booster dose.
COVID-19 vaccines and IP waiver proposals: One year on, where are we now?
A lot has changed over the last year since IP waiver proposals were first put forward - notably a massive rise in the production of COVID-19 vaccines. Komal Kalha of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)...